Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-08-03ARQT144Patrick Burnett plan to sell securities of Arcutis Biotherapeutics, Inc. under Form 144MEDIUM
Patrick Burnett filed Form 144 to notify SEC of plan to sell 955 units of Arcutis Biotherapeutics, Inc. securities around 2026-08-03, with aggregate market value of $24,941.54. The total outstanding units is 125083374.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in p...
Mid CapBiotechnology
2026-08-03ARQT144Todd Frank Watanabe plan to sell securities of Arcutis Biotherapeutics, Inc. under Form 144MEDIUM
Todd Frank Watanabe filed Form 144 to notify SEC of plan to sell 4375 units of Arcutis Biotherapeutics, Inc. securities around 2026-08-03, with aggregate market value of $114,261.00. The total outstanding units is 125083374.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transaction...
Mid CapBiotechnology
2026-08-03ARQT144Matsuda Masaru plan to sell securities of Arcutis Biotherapeutics, Inc. under Form 144MEDIUM
Matsuda Masaru filed Form 144 to notify SEC of plan to sell 1230 units of Arcutis Biotherapeutics, Inc. securities around 2026-08-03, with aggregate market value of $32,123.66. The total outstanding units is 125083374.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in p...
Mid CapBiotechnology